Barclays downgraded Galapagos (GLPG) to Underweight from Equal Weight with a price target of EUR 22, down from EUR 30. With Galapagos’ ongoing spin process not expected to complete until the middle of this year, a takeover is unlikely for the time being, the analyst tells investors in a research note. The firm is not expecting any major clinical data in the first half of 2025, which it thinks will keep “a lid on shares for the time being.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLPG:
